Isofol Medical is developing arfolitixorin – a drug candidate designed to enhance the efficacy of established cancer treatments. Subscribe to follow clinical progress, regulatory milestones and company updates delivered straight to your inbox.
This website uses cookies to improve your user experience, to provide a basis for improvement and further development of the website and to be able to direct more relevant offers to you.
Feel free to read our privacy policy. If you agree to our use, choose Allow all. If you want to change your choice afterwards, you will find that option at the bottom of the page.
